Trial · NCT07903324
Registered outcomes35
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 35
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of clinical malaria in children | From enrollment to Month 6 | Acute febrile illness defined as fever (temperature ≥38.0 Celsius) or fever reported in past 24 hours AND positive malaria rapid diagnostic test (RDT), confirmed by light microscopy (performed later), at scheduled or unscheduled study clinic visit |
| Secondary | Incidence of hospitalizations due to malaria | From enrollment to Month 6 | Incidence of admissions from clinic after a positive malaria RDT |
| Secondary | Incidence of hospitalizations due to any cause | From enrollment to Month 6 | Incidence of admissions from clinic after a positive malaria RDT |
| Secondary | Number of deaths due to any cause | From enrollment to Month 6 | Incidence of admissions from clinic after a positive malaria RDT |
| Secondary | Number of deaths due to malaria | From enrollment to Month 6 | Incidence of admissions from clinic after a positive malaria RDT |
| Secondary | Incidence of non-malarial febrile episodes in children | From enrollment to Month 6 | Incidence of participants experiencing acute febrile illness and negative malaria RDT at a scheduled or unscheduled study visit. |
| Secondary | Wrap attrition | From enrollment to Month 6 | The number of wraps lost or damaged and requiring replacement. |
| Secondary | Off-target use of wraps | From enrollment to Month 6 | Self-reported use for other purposes or use with other household members |
| Secondary | Incidence of malaria among mothers or other children (age < 5) in the household | From enrollment to Month 6 | Acute febrile illness defined as fever (temperature ≥38.0 Celsius) or fever reported in past 24 hours AND positive malaria rapid diagnostic test (RDT) at scheduled or unscheduled study clinic visit |
| Secondary | Perception of intervention | Month 6 | The median scores of the first 4 Likert-scale questions on the interview (e.g. Overall Experience). Higher scores indicate a more positive perception. |
| Secondary | Number of adverse reactions to wraps | From enrollment to Month 6 | Counts of the top 5 most common adverse reactions reported by participants on questionnaires and assessed by clinic staff. |
| Secondary | Number of participants with care-seeking events attributable to the wrap | From enrollment to Month 6 | Number of participants with care-seeking events attributable to the wrap. |
| Secondary | Number of participants with hospitalizations attributable to the wrap | From enrollment to Month 6 | Number of participants with hospitalizations attributable to the wrap |
| Secondary | Number of participants with death attributable to the wrap | From enrollment to Month 6 | Number of participants with death attributable to the wrap |
| Secondary | Change in child's height-for-weight | Enrollment, Month 3, Month 6 | Change in Z-score for height-for-weight. A height-for-weight Z-score indicates how a child's height compares with a reference population of children of the same weight. A score of 0 represents the reference average; positive values indicate above-average height-for-weight, and negative values indicate below-average height-for-weight. Z = 0: Average height-for-weight in the reference population Z = +1: One standard deviation above the reference average Z = -1: One standard deviation below the reference average Z = -2: Substantially below the reference average |
| Secondary | Change in child's height-for-age | Enrollment, Month 3, Month 6 | Change in Z-score for height-for-age. A height-for-age Z-score indicates how a child's height compares with a reference population of children of the same age. A score of 0 represents the reference average; positive values indicate above-average height-for-age, and negative values indicate below-average height-for-age. Z = 0: Average height-for-age in the reference population Z = +1: One standard deviation above the reference average Z = -1: One standard deviation below the reference average Z = -2: Substantially below the reference average |
| Secondary | Change in child's weight-for-age | Enrollment, Month 3, Month 6 | Change in Z-score for weight-for-age. Change in Z-score for weight-for-age. A weight-for-age Z-score indicates how a child's weight compares with a reference population of children of the same age. A score of 0 represents the reference average; positive values indicate above-average weight-for-age, and negative values indicate below-average weight-for-age. Z = 0: Average weight-for-age in the reference population Z = +1: One standard deviation above the reference average Z = -1: One standard deviation below the reference average Z = -2: Substantially below the reference average |
| Secondary | Change in child's acute malnutrition | From enrollment to Month 6 | Change in Mid-upper arm circumference (MUAC). |
| Secondary | Change in child's median score on the Mullen Scales of Early Learning | From enrollment to Month 6 | Change in median composite scores on the Mullen Scales of Early Learning. The Early Learning Composite from the Mullen Scales of Early Learning (MSEL) will be used to measure developmental functioning. The Early Learning Composite (ELC) is a standardized composite score derived from the 5 subtests measured on the MSEL. It has a mean of 100 and a standard deviation of 15. Higher scores indicate stronger performance. |
| Secondary | Change in child's mean score on the Mullen Scales of Early Learning | From enrollment to Month 6 | Change in mean composite scores on the Mullen Scales of Early Learning. The Early Learning Composite from the Mullen Scales of Early Learning (MSEL) will be used to measure developmental functioning. The Early Learning Composite (ELC) is a standardized composite score derived from the 5 subtests measured on the MSEL. It has a mean of 100 and a standard deviation of 15. Higher scores indicate stronger performance. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07903324/registered